149 related articles for article (PubMed ID: 19129504)
1. A new sensitive imaging biomarker for Parkinson disease?
Lang AE; Mikulis D
Neurology; 2009 Apr; 72(16):1374-5. PubMed ID: 19129504
[No Abstract] [Full Text] [Related]
2. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.
Vaillancourt DE; Spraker MB; Prodoehl J; Abraham I; Corcos DM; Zhou XJ; Comella CL; Little DM
Neurology; 2009 Apr; 72(16):1378-84. PubMed ID: 19129507
[TBL] [Abstract][Full Text] [Related]
3. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
Wichmann T; DeLong MR
Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
[No Abstract] [Full Text] [Related]
4. Individual dopaminergic neurons show raised iron levels in Parkinson disease.
Oakley AE; Collingwood JF; Dobson J; Love G; Perrott HR; Edwardson JA; Elstner M; Morris CM
Neurology; 2007 May; 68(21):1820-5. PubMed ID: 17515544
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid and clinical progression in Parkinson disease: potential biomarker for nigrostriatal failure.
Schiess M; Oh I
Arch Neurol; 2008 Jun; 65(6):698-9. PubMed ID: 18541788
[No Abstract] [Full Text] [Related]
6. Parkinson's disease is a neuropsychiatric disorder.
Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet AM; Damier P; Dubois B; François C; Houeto JL; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter ML; Yelnik J
Adv Neurol; 2003; 91():365-70. PubMed ID: 12442695
[No Abstract] [Full Text] [Related]
7. Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Stocchi F; Barbato L; Carbone A; Fabbrini G; Ruggieri S; Bonamartini A; Baffigo G; Agnoli A
Adv Neurol; 1993; 60():434-7. PubMed ID: 8420168
[No Abstract] [Full Text] [Related]
8. A tale of two etiologies: loss and recovery of olfactory function.
Albers MW; Marder KS
Ann Neurol; 2008 Feb; 63(2):132-4. PubMed ID: 18306414
[No Abstract] [Full Text] [Related]
9. Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.
Van Camp N; Blockx I; Verhoye M; Casteels C; Coun F; Leemans A; Sijbers J; Baekelandt V; Van Laere K; Van der Linden A
NMR Biomed; 2009 Aug; 22(7):697-706. PubMed ID: 19378292
[TBL] [Abstract][Full Text] [Related]
10. Iron in the Parkinsonian substantia nigra.
Gerlach M; Double K; Riederer P; Hirsch E; Jellinger K; Jenner P; Trautwein A; Youdim MB
Mov Disord; 1997 Mar; 12(2):258-60. PubMed ID: 9087993
[No Abstract] [Full Text] [Related]
11. A case of neuromyelitis optica with gadolinium-enhancing brain lesions and Parinaud syndrome.
Gilmore CP; Jacob A; Evangelou N
Arch Neurol; 2009 Jan; 66(1):140; author reply 140-1. PubMed ID: 19139317
[No Abstract] [Full Text] [Related]
12. Distinctive MRI findings in pallidopontonigral degeneration (PPND).
Frank AR; Wszolek ZK; Jack CR; Boeve BF
Neurology; 2007 Feb; 68(8):620-1. PubMed ID: 17310038
[No Abstract] [Full Text] [Related]
13. Anti-melanin antibodies are increased in sera in Parkinson's disease.
Double KL; Rowe DB; Carew-Jones FM; Hayes M; Chan DK; Blackie J; Corbett A; Joffe R; Fung VS; Morris J; Riederer P; Gerlach M; Halliday GM
Exp Neurol; 2009 Jun; 217(2):297-301. PubMed ID: 19289120
[TBL] [Abstract][Full Text] [Related]
14. Autonomic dysfunction in RBD--what can it teach us about disease progression?
Postuma RB; Gagnon JF; Montplaisir J
Sleep Med; 2008 Jul; 9(5):473-4. PubMed ID: 18024175
[No Abstract] [Full Text] [Related]
15. Preclinical biomarkers of Parkinson disease.
Wu Y; Le W; Jankovic J
Arch Neurol; 2011 Jan; 68(1):22-30. PubMed ID: 21220674
[TBL] [Abstract][Full Text] [Related]
16. [The status of imaging methods for the treatment of patients with Parkinson's syndrome].
Schwarz J; Gratz S; Hahn U; Förstl H; Jarnig M
Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S8-10. PubMed ID: 18437640
[TBL] [Abstract][Full Text] [Related]
17. Bilateral medial temporal lesions in Japanese encephalitis.
Jung KY; Chung CS; Park KW
Neurology; 2007 Apr; 68(16):1319. PubMed ID: 17438225
[No Abstract] [Full Text] [Related]
18. Effects of iodinated contrast agent on diffusion weighted magnetic resonance imaging.
Ogura A; Hayakawa K; Miyati T; Maeda F
Acad Radiol; 2009 Oct; 16(10):1196-200. PubMed ID: 19541508
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging in parkinsonisms.
Rutledge JN; Schallert T; Hall S
Adv Neurol; 1993; 60():529-34. PubMed ID: 8420184
[No Abstract] [Full Text] [Related]
20. Diagnostic evaluation of the substantia nigra.
McRitchie DA; Halliday GM; Pamphlett R
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):228-32. PubMed ID: 8804024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
